Cargando…
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for rheumatoid arthritis (RA). It is unknown why some RA patients fail to respond adequately to anti-TNF therapy, which limits the development of clinical biomarkers to predict response or new drugs to target ref...
Ejemplares similares
-
Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction
por: Klarenbeek, Paul L., et al.
Publicado: (2015) -
Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate
por: Altawil, Reem, et al.
Publicado: (2016) -
Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies
por: Curtis, Jeffrey R., et al.
Publicado: (2021) -
A Replication Study of the Association between Rheumatoid Arthritis and Deletion of the Late Cornified Envelope Genes LCE3B and LCE3C
por: Bergboer, Judith G. M., et al.
Publicado: (2012) -
Genetic mapping of cell type specificity for complex traits
por: Watanabe, Kyoko, et al.
Publicado: (2019)